Table 1. Patient demographics, cardiologic indications for CIED implantation with device information, and postoperative follow-up periods.

Patient no.	Age (yr)	Height (cm)	Weight (kg)	BMI (kg/m2)	Symptom (s)	Indication	Device	Model, company, and country	Follow-up (wk)
1	38	151.6	53.5	23.28	Palpitation, chest discomfort	Sick sinus syndrome	Pacemaker	Evia, Biotronik, Germany	214.4
2	29	166	55	19.96	Sudden cardiac arrest	Ventricular fibrillation	ICD	Incepta ICD, Boston Scientific, United States	130.4
3	34	155	51	21.09	Syncope	Dilated cardiomyopathy	ICD	Ellipse DR, St. Jude Medical, United States	126.0
4	16	162	49	18.67	Sudden cardiac arrest	Dilated cardiomyopathy	ICD	Ellipse DR, St. Jude Medical, United States	76.0
5	22	151	51.9	22.49	Dizziness	Chemotherapy-induced dilated cardiomyopathy	CRT-D	VivaQuad XT CRT-D, Medtronic, Ireland	65.4
6	37	154	48	20.24	Syncope	High-degree atrioventricular block	Pacemaker	Accolade EL, Boston Scientific, United States	59.1
7	18	160	48.3	18.75	Syncope	Sick sinus syndrome	Pacemaker	Accolade EL, Boston Scientific, United States	57.4
8	25	153	43	18.37	Syncope	Hypertrophic cardiomyopathy	ICD	Evera MRI XT DR, Medtronic, Ireland	32.4
9	20	0162.1	53	20.17	Dyspnea, dizziness	High-degree atrioventricular block	Pacemaker	Advisa DR MRI, Medtronic, Ireland	36.3
10a)	20	161	45.2	17.44	Dyspnea	Dilated cardiomyopathy	ICD	Ellipse DR, St. Jude Medical, United States	84.1
Mean	25.9	157.6	49.8	20.05	-	-	-		88.2

CIED, cardiac implantable electronic device; BMI, body mass index; ICD, implantable cardioverter-defibrillator; CRT-D, cardiac resynchronization therapy defibrillator.

^a)A patient who received concomitant augmentation mammoplasty together with CIED placement.